ScholarIQanswers from OpenAlex
Ospedale San Carlo
InstitutionResearch output, impact & collaborations
Ospedale San Carlo is a institution indexed in ScholarIQ from OpenAlex.
What is known about Ospedale San Carlo?
ScholarIQrecord summary
Ospedale San Carlo is a research organisation in Potenza, IT. OpenAlex records 5,751 works and 283,889 citations for it. 1,221 researchers list it as their most recent affiliation.
How many works does Ospedale San Carlo have?
ScholarIQindexed works
Ospedale San Carlo has 5,751 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ospedale San Carlo have?
ScholarIQcitation count
Ospedale San Carlo has 283,889 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Ospedale San Carlo?
ScholarIQresearcher count
Ospedale San Carlo has 1,221 researchers in the ScholarIQ index.
What is the average h-index at Ospedale San Carlo?
ScholarIQavg h-index
Ospedale San Carlo has an average h-index of 32 in OpenAlex.
What is the ROR of Ospedale San Carlo?
ScholarIQror
The ROR for Ospedale San Carlo is on the source record.
What is the OpenAlex record for Ospedale San Carlo?
ScholarIQopenalex
The OpenAlex for Ospedale San Carlo is on the source record.
Who are the most-cited researchers behind Ospedale San Carlo?
ScholarIQtop researchers by citations
What are the most-cited papers on Ospedale San Carlo?
ScholarIQmost cited works
Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial
C. Aschele, L. Cionini, Sara Lonardi, Carmine Pinto, Stefano Cordio, Gerardo Rosati, Salvatore Artale, A. Tagliagambe, Giovanni Ambrosini, Paola Rosetti, Andrea Bonetti, Maria Emanuela Negru, Maria Chiara Tronconi, Gabriele Luppi, Giovanni Silvano, Domenico Corsi, Anna Maria Bochicchio, Germana Chiaulon, Maurizio Gallo, Luca Boni
A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma
Gerardo Rosati, G. Ambrosini, Sandro Barni, B. Andreoni, G Corradini, Giovanna Luchena, Bruno Daniele, Fernando Gaion, Giovanni William Oliverio, Mary Duro, G. Martignoni, N. Pinna, Pietro Sozzi, G. Pancera, Gaspare Solina, Gianfranco Pavia, Sandro Pignata, F. Bing Johnson, Roberto Labianca, Giovanni Apolone, Alberto Zaniboni, Marta Monteforte, Eva Negri, Valter Torri, Paola Mosconi, Roldano Fossati
Lapatinib in breast cancer
Domenico Bilancia, Gerardo Rosati, Angelo Dinota, Domenico Germano, Rosangela Romano, Luigi Manzione
Preoperative fluorouracil (FU)-based chemoradiation with and without weekly oxaliplatin in locally advanced rectal cancer: Pathologic response analysis of the Studio Terapia Adiuvante Retto (STAR)-01 randomized phase III trial
C. Aschele, Carmine Pinto, Stefano Cordio, Gerardo Rosati, A. Tagliagambe, Salvatore Artale, Paola Rosetti, Sara Lonardi, Luca Boni, L. Cionini, on behalf of STAR Network Investigators
Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer
Timothy Iveson, Alberto Sobrero, Takayuki Yoshino, Ioannis Souglakos, Fang‐Shu Ou, Jeffrey P. Meyers, Qian Shi, Axel Grothey, Mark Saunders, Roberto Labianca, Takeharu Yamanaka, Ioannis Boukovinas, Niels Henrik Holländer, Fabio Galli, Kentaro Yamazaki, Vassilis Georgoulias, Rachel Kerr, Eiji Oki, Sara Lonardi, Andrea Harkin, Gerardo Rosati, James Paul
How much of the research on Ospedale San Carlo is open access?
ScholarIQopen access share
82%OPEN ACCESS